SCHEMBL19359772

SCHEMBL19359772

CCCC(C)C(C)OC(=O)C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 1/20 0.39
MAPT P10636 1/20 0.35
METAP1 P53582 1/20 0.34
CHRM1 P11229 1/20 0.32
AKR1A1 P14550 1/20 0.32
CHRM3 P20309 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
ADRA1A P35348 1/20 0.32
HRH1 P35367 1/20 0.32
DRD3 P35462 1/20 0.32
SLC6A3 Q01959 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP3A4 P08684 2/20 0.31
TSHR P16473 2/20 0.31
NFKB1 P19838 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31
CTSK P43235 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16973566 0.85 FAAH (0.41) MAPT
SCHEMBL16795949 0.85 FAAH (0.41) MAPT
SCHEMBL20747713 0.85 METAP1 (0.36) MAPTMETAP1CHRM1AKR1A1CHRM3
SCHEMBL25888320 0.84 PRKCA (0.43) PRKCAMETAP1CHRM1AKR1A1CHRM3
SCHEMBL18558892 0.81 PRKCA (0.41) PRKCACHRM1AKR1A1CHRM3HTR2A
SCHEMBL23198152 0.79 PRKCA (0.41) PRKCACHRM1AKR1A1CHRM3HTR2A
SCHEMBL2934272 0.79 PRKCA (0.41) PRKCACHRM1AKR1A1CHRM3HTR2A
SCHEMBL13073714 0.79 PRKCA (0.41) PRKCACHRM1AKR1A1CHRM3HTR2A
SCHEMBL14990889 0.79 METAP1 (0.39) METAP1CHRM1AKR1A1CHRM3HTR2A
SCHEMBL19359969 0.77 CTSK (0.35) METAP1CHRM1AKR1A1CHRM3HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170267639-A1 Process for Synthesizing Oxidized Lactam Compounds JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT 2017-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170267639-A1 Process for Synthesizing Oxidized Lactam Compounds COASY, DHPS, OXA1L PRKCA 2448/4885MAPT 3460/4885METAP1 3030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.